---
layout: post
title: "RAAP Policy Study: Medicare's \"Maximum Fair Price\" Is Not a Transferable Model for State Drug Pricing"
date: 2026-02-18T18:30:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/raap-policy-study-medicares-maximum-fair-price-is-not-a-transferable-model-for-state-drug-pricing-302691856.html
significance: 7.00
---

<p>WASHINGTON, Feb. 18, 2026 /PRNewswire/ -- As states explore new strategies to address prescription drug affordability, the Rare Access Action Project (RAAP) today released an issue paper warning policymakers against attempting to replicate Medicare's Maximum Fair Price (MFP) framework at...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/raap-policy-study-medicares-maximum-fair-price-is-not-a-transferable-model-for-state-drug-pricing-302691856.html)

**Published:** 2026-02-18 18:30:00 +0000

**Significance Score:** 7.00

[View original](https://www.prnewswire.com/news-releases/raap-policy-study-medicares-maximum-fair-price-is-not-a-transferable-model-for-state-drug-pricing-302691856.html)
